Prozymi Biolabs

Prozymi Biolabs

Created 29 Oct 2024
Last activity about 2 months ago

Prozymi Biolabs develop enzyme-based technology that will revolutionize the gluten-free sector by enabling the baking of gluten-free bread using wheat flour.

Andreas Andreou
lead researcher

Planetary Impact

The outcomes of our project provide multidimensional socio-economic benefits, exemplifying the principles of a circular economy that connects the economy to individual consumers. Environmental: Existing gluten-free products often rely on alternative raw materials such as rice, tapioca, and quinoa flour. However, rice production consumes a significant amount of fresh water, contributes to pesticide use, and generates methane emissions. Our enzyme-based products will utilize locally sourced wheat and barley flour, following traditional formulations. By avoiding imported raw materials, we help protect indigenous populations worldwide from rising product prices, as seen in Bolivia and Peru, where increased demand for quinoa has led to affordability challenges. Additionally, reducing our reliance on imported goods will positively impact the environment by minimizing transportation fuels, aligning with government priorities for carbon footprint reduction. Economic:This project offers substantial economic benefits to the UK by creating high-quality jobs in the food and drink industry. Employment opportunities at Prozymi, along with increased demand for gluten-free products, will help safeguard and expand jobs in the UK wheat production sector. Using local wheat and barley varieties will also boost sales and revenue for the farming industry. By disrupting traditional food production methods and contributing to the growth of the gluten-free food market, our gluten-degrading enzymes will relieve some financial pressure on the NHS by reducing the costs of prescribed goods for individuals with coeliac disease. Regarding irritable bowel syndrome (IBS), direct care costs—including healthcare delivery, investigations, and treatments—are significant, estimated to range from £45.6 million to £200 million per annum in the UK. Societal:Consumers will benefit from access to high-quality gluten-free products at lower prices, making them more affordable for low-income groups. Maintaining a gluten-free diet can require persistent dedication to a restricted eating plan, which may lead to social isolation and negative psychosocial effects. We aim to alleviate these challenges by offering affordable, healthy, and sustainable products of exceptional quality. By establishing a reputable and recognized company, we seek to create new jobs and economic opportunities within the food and drink industry, ultimately enhancing societal well-being.

Methodology

Prozymi Biolabs utilizes a combination of bioinformatics and laboratory-based techniques  to discover, optimize, and engineer gluten degrading enzymes. These enzymes are designed to specifically target the toxic components of gluten while preserving the harmless parts. This innovative approach aims to allow for the baking of gluten-free bread using wheat, resulting in a product with the same texture, flavor, and aroma as traditional bread.

Work Package
Type
Status
Regulatory & RTM Strategy
business development
TO DO
Investor Outreach & Networking Support
fundraising
TO DO
Identifying Relevant Fundraising Opportunities
fundraising
TO DO
Team Development, Recruitment & Strategic Partnerships
business development
TO DO
Investment Readiness Support
business development
TO DO

Discussions